ORIGINAL RESEARCH
Published on 13 Mar 2025
Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment
doi 10.3389/fimmu.2025.1448438
- 4,359 views
- 2 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume III
Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume III
4,273
Total downloads
17k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CORRECTION
Published on 21 Feb 2025
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
doi 10.3389/fimmu.2025.1571555
- 1,115 views
ORIGINAL RESEARCH
Published on 03 Feb 2025
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
doi 10.3389/fimmu.2025.1485817
- 4,598 views
- 6 citations
ORIGINAL RESEARCH
Published on 16 Dec 2024
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
doi 10.3389/fimmu.2024.1485461
- 3,705 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: